Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease (vol 236, pg 1701, 2019)

被引：0

作者：

Cherian, Ajeesh Koshy ^{[1
]}

Kucinski, Aaron ^{[1
]}

Wu, Ryan ^{[1
]}

de Jong, Inge E. M. ^{[2
]}

Sarter, Martin ^{[1
]}

机构：

[1] Univ Michigan, Dept Psychol, 530 Church St, Ann Arbor, MI 48109 USA

[2] H Lundbeck & Co AS, Div Neurodegenerat, Valby, Denmark

来源：

PSYCHOPHARMACOLOGY | 2020年 / 237卷 / 01期

关键词：

D O I：

10.1007/s00213-019-05375-0

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

After publication of this paper, the authors determined that the “Acknowledgments” section was omitted. Below is the “Acknowledgments” statement.

引用

页码：289 / 289

页数：1

共 38 条

[1] Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson’s disease
Ajeesh Koshy Cherian
Aaron Kucinski
Ryan Wu
Inge E. M. de Jong
Martin Sarter
Psychopharmacology, 2019, 236 : 1701 - 1715
[2] Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease
Cherian, Ajeesh Koshy
Kucinski, Aaron
Wu, Ryan
de Jong, Inge E. M.
Sarter, Martin
PSYCHOPHARMACOLOGY, 2019, 236 (06) : 1701 - 1715
[3] Correction to: Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson’s disease
Ajeesh Koshy Cherian
Aaron Kucinski
Ryan Wu
Inge E. M. de Jong
Martin Sarter
Psychopharmacology, 2020, 237 : 289 - 289
[4] Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements
Kucinski, Aaron
de Jong, Inge E. M.
Sarter, Martin
EUROPEAN JOURNAL OF NEUROSCIENCE, 2017, 45 (02) : 217 - 231
[5] RETRACTION: Vitamin D Reduces Falls and Hip Fractures in Vascular Parkinsonism but Not in Parkinson's Disease (Retraction of Vol 9, Pg 171, 2013)
Sato, Y.
Iwamoto, J.
Honda, Y.
Amano, N.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 787 - 787
[6] Vitamin D Reduces Falls and Hip Fractures in Vascular Parkinsonism but Not in Parkinson's Disease (Expression of Concern of Vol 9, Pg 171, 2013)
Sato, Y.
Iwamoto, J.
Honda, Y.
Amano, N.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 183 - 183
[7] What predicts falls in Parkinson disease? Observations from the Parkinson's Foundation Registry (vol 8, pg 214, 2018)
Parashos
NEUROLOGY-CLINICAL PRACTICE, 2018, 8 (04) : 278 - 278
[8] Oxidative stress in rotenone model of Parkinson's disease: Amelioration by co-treatment of centrophenoxine
Verma, R.
Nehru, B.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S131 - S131
[9] Behavioral alterations in rotenone model of Parkinson's disease: Attenuation by co-treatment of centrophenoxine
Nehru, Bimla
Verma, Ranjeet
Khanna, Pooja
Sharma, Suresh Kumar
BRAIN RESEARCH, 2008, 1201 : 122 - 127
[10] Immunomodulatory Drugs Alleviate L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease (vol 34, pg 1818, 2019)
Boi, L.
Pisanu, A.
Greig, N. H.
Scerba, M. T.
Tweedie, D.
Mulas, G.
Fenu, S.
Carboni, E.
Spiga, S.
Carta, A. R.
MOVEMENT DISORDERS, 2021, 36 (01) : 275 - 275

← 1 2 3 4 →